$QTTB News

HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

Q32 Bio Files Prospectus For Offer And Resale Of 6.875M Shares By Selling Stockholders

Q32 Bio: Bempikibart's Progress Keeps Me Bullish

Why Is Q32 Bio Stock Falling Wednesday?

$100 Invested In Q32 Bio 5 Years Ago Would Be Worth This Much Today

Q32 Bio Launches $200M Public Offering Of Its Common Stock

Q32 Bio: 'Strong Buy' On Solid Bempikibart SIGNAL-AA Study Data And Catalysts

Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

Oppenheimer Maintains Outperform on Q32 Bio, Raises Price Target to $40

Q32 Bio Stock Soars After Patchy Hair Loss Study - Here's Why

Q32 Bio Announces 36-Week Topline Results From Part B Of SIGNAL-AA Phase 2a Clinical Trial Evaluating Bempikibart In Patients With Severe Or Very Severe AA

Q32 Bio To Reveal 36-Week Topline Results From Part B Of The SIGNAL-AA Phase 2a Clinical Trial Evaluating Bempikibart In Patients With Severe Or Very Severe Aa On July 13, 2026

Q32 Bio Files Prospectus For $300M Offering

Why Is Q32 Bio Stock Gaining Friday?

QTTB Stock Hits 18-Month High, Heads Toward Recording Its Best Ever Month – What’s Driving The Investor Optimism?

Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB)

Q32 Bio Announces $55 Million Private Placement Financing

Q32 Bio Inks Securities Purchase Agreement With New, Current Institutional Investors For ~$55M Private Placement Of Common Stock, Pre-Funded Warrants

Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet

Mizuho Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $14